JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo

10th January 2024 Uncategorised 0

JPM24: BioMarin’s new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
kdunleavy
Wed, 01/10/2024 – 11:11

More: JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
Source: fierce